Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
20 mg+12.5 mg
2 x 10
৳10.00

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →

Save on this medicine

Same active ingredient — pay up to 30% less

These brands contain the same active ingredient (Olmesartan Medoxomil + Hydrochlorothiazide). Same strength and form. Confirm the switch with your doctor or pharmacist.

From ৳10.00 (2 x 10)
Available as: 20 mg+12.5 mg · 2 x 10 20 mg+12.5 mg 20 mg+12.5 mg 20 mg+12.5 mg

Indications & Uses

Rezor Plus is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Hypertension: The usual starting dose is 20/12.5 mg one tablet once daily. Dosing should be individualized. Depending on the blood pressure response, the dose may be titrated at intervals of 2-4 weeks to two tablets 40/25 once daily.

Side Effects

The common side-effects are nausea, headache, dizziness, hyperuricemia, upper respiratory tract infection and urinary tract infection. Other adverse effects are chest pain, back pain, peripheral edema, abdominal pain, dyspepsia, gastroenteritis, diarrhea.

Cautions & Contraindications

Warnings & Precautions

Periodic determination of serum electrolytes should be performed at appropriate intervals to detect possible electrolyte imbalance like hypokalemia, hyponatremia and hypochloremic alkalosis. Hyperuricemia may occur in certain patients receiving thiazide therapy. Impaired renal function.

Contraindications

The combination of Olmesartan and Hydrochlorothiazide is contraindicated in patients who are hypersensitive to any component of this product. Because of the Hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

Drug Interactions

Open checker →
Last updated: 18 Aug 2026